Pulse Biosciences Inc [PLSE] stock prices are up 28.71% to $15.51 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PLSE shares have gain 38.61% over the last week, with a monthly amount glided 13.13%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Pulse Biosciences Inc [NASDAQ: PLSE] stock has seen the most recent analyst activity on July 27, 2021, when Stephens initiated its Overweight rating and assigned the stock a price target of $28. Previously, Maxim Group started tracking the stock with Buy rating on March 11, 2021, and set its price target to $40. On January 26, 2021, H.C. Wainwright reiterated its Buy rating and revised its price target to $40 on the stock. H.C. Wainwright upgraded its rating to a Buy and increased its price target to $16 on May 12, 2020. H.C. Wainwright downgraded its rating to a Neutral and reduced its price target to $6 on February 14, 2020. H.C. Wainwright started tracking with a Buy rating for this stock on February 25, 2019, and assigned it a price target of $27.
The stock price of Pulse Biosciences Inc [PLSE] has been fluctuating between $3.78 and $14.96 over the past year. Pulse Biosciences Inc [NASDAQ: PLSE] shares were valued at $15.51 at the most recent close of the market.
Analyzing the PLSE fundamentals
Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -25.65%, Pretax Profit Margin comes in at -24.45%, and Net Profit Margin reading is -24.45%. To continue investigating profitability, this company’s Return on Assets is posted at -0.87, Equity is -0.88 and Total Capital is -1.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.36 points at the first support level, and at 11.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.36, and for the 2nd resistance point, it is at 19.20.
Ratios To Look Out For
It’s worth pointing out that Pulse Biosciences Inc [NASDAQ:PLSE]’s Current Ratio is 7.06. As well, the Quick Ratio is 7.06, while the Cash Ratio is 6.87.
Transactions by insiders
Recent insider trading involved Barrett Burke Thomas, President and CEO, that happened on May 20 ’24 when 10000.0 shares were purchased. Director, DUGGAN ROBERT W completed a deal on Dec 12 ’23 to buy 17999.0 shares. Meanwhile, Director DUGGAN ROBERT W bought 90118.0 shares on Dec 11 ’23.
